HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Lajos Pusztai Selected Research

Breast Neoplasms (Breast Cancer)

1/2016Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer.
12/2015Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
12/2015Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.
12/2015Breast cancer: Chemotherapy and the recurrence score-results as expected?
10/2015Predictive and Prognostic Value of the TauProtein in Breast Cancer.
8/2015CCR 20th Anniversary Commentary: Divide and Conquer-Breast Cancer Subtypes and Response to Therapy.
8/2015A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer.
8/2015Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.
8/2015Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.
7/2015A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Lajos Pusztai Research Topics

Disease

139Breast Neoplasms (Breast Cancer)
01/2016 - 04/2002
112Neoplasms (Cancer)
12/2015 - 11/2002
15Carcinoma (Carcinomatosis)
10/2015 - 04/2003
11Neoplasm Metastasis (Metastasis)
06/2015 - 11/2005
7Residual Neoplasm
02/2012 - 04/2004
3Inflammatory Breast Neoplasms
11/2013 - 02/2011
3Disease Progression
04/2011 - 03/2006
2Adenocarcinoma
03/2013 - 01/2013
2Tics (Tic)
04/2012 - 08/2010
2Noninfiltrating Intraductal Carcinoma (DCIS)
07/2007 - 01/2006
1Hyperinsulinism (Hyperinsulinemia)
07/2014
1Obesity
07/2014
1Inflammation
07/2014
1Thymoma (Thymic Carcinoma)
05/2014
1Neutropenia
01/2013
1Hypersensitivity (Allergy)
01/2013
1Melanoma (Melanoma, Malignant)
01/2012

Drug/Important Bio-Agent (IBA)

46Estrogens (Estrogen)FDA Link
12/2015 - 07/2003
22Paclitaxel (Taxol)FDA LinkGeneric
03/2013 - 02/2004
21Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2013 - 04/2003
20Doxorubicin (Adriamycin)FDA LinkGeneric
03/2013 - 01/2003
17Epidermal Growth Factor Receptor (EGF Receptor)IBA
12/2015 - 04/2004
17trastuzumab (Herceptin)FDA Link
08/2015 - 04/2002
16HormonesIBA
04/2015 - 09/2003
16Fluorouracil (Carac)FDA LinkGeneric
01/2012 - 04/2003
12DNA (Deoxyribonucleic Acid)IBA
01/2015 - 12/2006
11Messenger RNA (mRNA)IBA
05/2014 - 06/2005
10taxaneIBA
10/2015 - 08/2005
10Biological Markers (Surrogate Marker)IBA
01/2015 - 09/2003
8TamoxifenFDA LinkGeneric
04/2013 - 04/2007
7Proteins (Proteins, Gene)IBA
04/2015 - 09/2003
7RNA (Ribonucleic Acid)IBA
01/2015 - 06/2003
7ParaffinIBA
11/2013 - 01/2003
6Progesterone Receptors (Progesterone Receptor)IBA
12/2015 - 03/2008
6Phosphotransferases (Kinase)IBA
01/2015 - 11/2010
6Epirubicin (Ellence)FDA LinkGeneric
01/2012 - 06/2005
5Phenobarbital (Luminal)FDA Link
01/2015 - 08/2005
5AnthracyclinesIBA
01/2013 - 04/2004
5docetaxel (Taxotere)FDA Link
01/2012 - 04/2002
4tau Proteins (tau Protein)IBA
10/2015 - 06/2005
4lapatinib (GW572016)FDA Link
02/2015 - 11/2005
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2012 - 04/2004
3MicroRNAs (MicroRNA)IBA
01/2015 - 08/2010
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2014 - 01/2008
3Small Interfering RNA (siRNA)IBA
04/2014 - 11/2010
3Formaldehyde (Formol)FDA Link
11/2013 - 05/2008
3TaxoidsIBA
01/2013 - 07/2004
3Complementary DNA (cDNA)IBA
01/2006 - 03/2003
3Transcription Factors (Transcription Factor)IBA
12/2005 - 09/2003
3Peptide Hydrolases (Proteases)IBA
03/2004 - 03/2003
2exemestane (Aromasin)FDA Link
01/2016 - 07/2015
2everolimusFDA Link
07/2015 - 07/2014
2dasatinib (BMS 354825)FDA Link
10/2014 - 05/2010
2Metformin (Glucophage)FDA LinkGeneric
07/2014 - 08/2011
2imatinib (Gleevec)FDA Link
05/2014 - 10/2004
2Investigational DrugsIBA
05/2014 - 07/2012
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2014 - 01/2013
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
09/2013 - 03/2012
2ixabepilone (BMS 247550)FDA Link
03/2013 - 01/2013
2P-GlycoproteinIBA
03/2013 - 08/2005
2TubulinIBA
03/2013 - 01/2013
2capecitabine (Xeloda)FDA Link
01/2012 - 09/2003
2Protein Kinases (Protein Kinase)IBA
11/2010 - 02/2004
2Biological Tumor Markers (Tumor Markers)IBA
10/2010 - 05/2008
2Estrogen ReceptorsIBA
07/2004 - 03/2003
2Cell Adhesion MoleculesIBA
03/2004 - 09/2003
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2004 - 09/2003
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2016
1PlatinumIBA
01/2015
1Glucose (Dextrose)FDA LinkGeneric
01/2015
1Interferon Type IIBA
11/2014
1AdipokinesIBA
07/2014
1tranilast (N 5')IBA
05/2014
1Sirolimus (Rapamycin)FDA Link
05/2014
1sunitinib (Sutent)FDA Link
05/2014
1Protein Kinase InhibitorsIBA
05/2014
1anthra(1,9-cd)pyrazol-6(2H)-oneIBA
05/2014
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
05/2014
1Stearoyl-CoA DesaturaseIBA
01/2013
1letrozole (Femara)FDA LinkGeneric
01/2013
1Interleukin-8 (Interleukin 8)IBA
01/2013
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2013
1CyclinsIBA
01/2013
1Carbon MonoxideIBA
07/2012
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2012
1N 30IBA
05/2012
1Estrogen Receptor alphaIBA
04/2012
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
02/2012
1Monomeric GTP-Binding ProteinsIBA
02/2012
1centromere protein AIBA
01/2012
1AntigensIBA
01/2012

Therapy/Procedure

92Drug Therapy (Chemotherapy)
12/2015 - 11/2002
11Adjuvant Chemotherapy
06/2015 - 02/2004
7Neoadjuvant Therapy
08/2015 - 06/2005
3Segmental Mastectomy (Lumpectomy)
08/2015 - 07/2008
3Aftercare (After-Treatment)
03/2015 - 11/2002
3Combination Drug Therapy (Combination Chemotherapy)
01/2012 - 01/2010
2Chemoprevention
01/2016 - 01/2006
1Immunotherapy
01/2015
1Cell Transplantation
04/2012